EXCLUSIVE: Biocad's vaccine will be more effective against new covid-19 strains

A new vaccine against coronavirus BCD-250 developed by the Russian biotechnology company Biocad(a participant of the Made in Russia project) is optimized with the new strain "delta" in mind, it can be adapted to fight against possible other covid-19 strains in the future, the company's press service told the project.

"It (the vaccine - ed.) is very easily upgradable. That is, it is expected that each new batch can be assembled like a 'construction kit': each time it will be 'stitched' inside exactly the strain of coronavirus that is considered the most dangerous or the most common at the moment," Biocad told Made in Russia.

They specified that the vaccine has already been optimized with the presence of the "delta" strain.

Earlier, the Ministry of Health of Russia granted Biocad permission to conduct Phase I and Phase II trials of the recombinant vector vaccine. The trial is expected to be completed by December 31, 2026 and will involve 360 participants.

Made in Russia // Made in Russia

Author: Karina Kamalova